Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Buda

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
JACC. Cardiovascular Imaging|August 11, 2020
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking ConditionsDario Genovesi, Giuseppe Vergaro, Assuero Giorgetti, et al.
Leukemia Research|December 7, 2007
Lack of association of NQO1 and GSTP1 polymorphisms with multiple myeloma riskValentina Maggini, Gabriele Buda, Sara Galimberti, et al.
European Journal of Clinical Investigation|July 18, 2024
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosisRaffaella Cassano Cassano, Dario Genovesi, Giuseppe Vergaro, et al.
Frontiers in Medicine|September 13, 2021
Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell TransplantationGabriele Buda, Maria Livia Del Giudice, Elisabetta Antonioli, et al.
Frontiers in Cell and Developmental Biology|July 22, 2021
Mesangiogenic Progenitor Cells Are Tissue Specific and Cannot Be Isolated From Adipose Tissue or Umbilical Cord BloodSerena Barachini, Marina Montali, Francesca M Panvini, et al.
Biomolecules|November 27, 2021
Piezoelectric Signals in Vascularized Bone RegenerationDelfo D'Alessandro, Claudio Ricci, Mario Milazzo, et al.
Annals of Hematology|June 10, 2010
Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicinGabriele Buda, Deborah Ricci, C Chris Huang, et al.
Journal of Clinical Medicine|July 12, 2020
Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative NeoplasmsEdoardo Benedetti, Rita Tavarozzi, Riccardo Morganti, et al.
Leukemia Research|March 6, 2012
Could age modify the effect of genetic variants in IL6 and TNF-α genes in multiple myeloma?Alessandro Martino, Gabriele Buda, Valentina Maggini, et al.
British Journal of Haematology|May 10, 2007
MDR1 polymorphism influences the outcome of multiple myeloma patientsGabriele Buda, Valentina Maggini, Sara Galimberti, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
JACC. Cardiovascular Imaging|August 11, 2020
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking ConditionsDario Genovesi, Giuseppe Vergaro, Assuero Giorgetti, et al.
Leukemia Research|December 7, 2007
Lack of association of NQO1 and GSTP1 polymorphisms with multiple myeloma riskValentina Maggini, Gabriele Buda, Sara Galimberti, et al.
European Journal of Clinical Investigation|July 18, 2024
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosisRaffaella Cassano Cassano, Dario Genovesi, Giuseppe Vergaro, et al.
Frontiers in Medicine|September 13, 2021
Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell TransplantationGabriele Buda, Maria Livia Del Giudice, Elisabetta Antonioli, et al.
Frontiers in Cell and Developmental Biology|July 22, 2021
Mesangiogenic Progenitor Cells Are Tissue Specific and Cannot Be Isolated From Adipose Tissue or Umbilical Cord BloodSerena Barachini, Marina Montali, Francesca M Panvini, et al.
Biomolecules|November 27, 2021
Piezoelectric Signals in Vascularized Bone RegenerationDelfo D'Alessandro, Claudio Ricci, Mario Milazzo, et al.
Annals of Hematology|June 10, 2010
Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicinGabriele Buda, Deborah Ricci, C Chris Huang, et al.
Journal of Clinical Medicine|July 12, 2020
Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative NeoplasmsEdoardo Benedetti, Rita Tavarozzi, Riccardo Morganti, et al.
Leukemia Research|March 6, 2012
Could age modify the effect of genetic variants in IL6 and TNF-α genes in multiple myeloma?Alessandro Martino, Gabriele Buda, Valentina Maggini, et al.
British Journal of Haematology|May 10, 2007
MDR1 polymorphism influences the outcome of multiple myeloma patientsGabriele Buda, Valentina Maggini, Sara Galimberti, et al.
Pageof 14